Using micro-Doppler radar to assess ACL reconstruction outcomes
The Use of Micro-Doppler Radar to Identify Service Members at Risk for Musculoskeletal Injury: A Gold Standard Comparison
This study is testing if a new radar technology can better tell apart people who have had ACL surgery from those who haven't by looking at their movements during activities.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | All |
| Sponsor | Milton S. Hershey Medical Center Academic / other |
| Locations | 2 sites (Annville, Pennsylvania and 1 other locations) |
| Trial ID | NCT05521126 on ClinicalTrials.gov |
What this trial studies
This research aims to validate the use of micro-Doppler signal (MDS) technology in differentiating individuals who have undergone anterior cruciate ligament (ACL) reconstruction from those who have not. The study will compare movement data from a group of adults aged 18-40 who have had ACL surgery with a control group of healthy adults. Participants will perform functional activities while their movements are captured using both MDS radar and biomechanical motion capture systems. The goal is to determine if MDS can more accurately identify individuals at high risk for musculoskeletal injuries compared to traditional methods.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-40 who have undergone ACL reconstruction between 9 and 24 months prior to recruitment, with no current musculoskeletal injuries.
Not a fit: Patients outside the age range of 18-40, those with a history of lower extremity surgery, or current musculoskeletal injuries may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved methods for identifying individuals at high risk for re-injury after ACL reconstruction.
How similar studies have performed: Other studies have shown promise in using advanced motion capture technologies for assessing injury risk, but the application of micro-Doppler radar in this context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: High risk cohort * age 18-40 * history of ACL reconstruction * no current musculoskeletal injuries * ACL repair between 9 and 24 months prior to recruitment Control cohort * age 18-40 * never had lower extremity surgery Exclusion Criteria: High risk cohort * age \<18 or \>40 * pregnancy * institutionalization * history of cerebral vascular accident * unable to provide informed consent * inability to perform study activities * history of hip or knee replacement * inability to walk or jump without a limp * current neuromuscular disease * any surgery in the last 6 months Control cohort * age \< 18 or \> 40 * pregnancy * institutionalization * history of Cerebral Vascular Accident * unable to provide informed consent * inability to perform study activities * history of knee or hip replacement * inability to walk or jump without a limp * current neuromuscular disease * history of lower extremity surgery * any surgery in the last 6 months
Where this trial is running
Annville, Pennsylvania and 1 other locations
- Lebanon Valley College — Annville, Pennsylvania, United States (Recruiting)
- Pennsylvania State University College of Medicine — Hershey, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Cayce A Onks, DO, MS — Milton S. Hershey Medical Center
- Study coordinator: Leonard A Kishel, MA
- Email: lkishel@pennstatehealth.psu.edu
- Phone: 717-531-0003
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.